Pharma giant refused costs in HSE tender case

Pharma giant refused costs in HSE tender case

Because of its interest in the outcome, the pharmaceutical giant was joined as a notice party to a Commercial Court action brought by Sanofi against the HSE’s awarding of a tender for the six-in-one vaccine last January

Glaxosmithkline has been refused most of its costs following a legal row in which it said the “safety and efficacy” of one of its vaccines was being challenged by a global rival.

Please Subscribe or Log in to continue reading

Subscribe Login

Independent journalism every day

With digital access you can read The Business Post whenever, wherever, and however you want.

  • Unlimited access to all sections of The Business Post on desktop, tablet and mobile.
  • Breaking news, comment and analysis from the best Business Post writers seven days a week.
  • Live blogs of major news events
  • Videos and podcasts from some of the industry's most respected journalists such as Tom Lyons, Susan Mitchell and Ian Guider
  • Access to The Business Post's extensive archive​

Related Articles

More from The Business Post